Advanced search
Publication Cover
Acta Orthopaedica Scandinavica Volume 73, 2002 - Issue 4
Journal homepage
594
Views
84
CrossRef citations to date
0
Altmetric
Research Article

Early postoperative mortality after 67,548 total hip replacements

Stein Atle Lie Section for Medical Statistics, Armauer Hansens Hus, University of Bergen, Haukeland Hospital, NO-5021 Bergen, Norway, E-mail: [email protected], Department of Orthopaedics, Haukeland University Hospital, NO-5021 Bergen, Norway
,
Lars Birger Engesaeter Section for Medical Statistics, Armauer Hansens Hus, University of Bergen, Haukeland Hospital, NO-5021 Bergen, Norway, E-mail: [email protected], Department of Orthopaedics, Haukeland University Hospital, NO-5021 Bergen, Norway
,
Leif Ivar Havelin Section for Medical Statistics, Armauer Hansens Hus, University of Bergen, Haukeland Hospital, NO-5021 Bergen, Norway, E-mail: [email protected], Department of Orthopaedics, Haukeland University Hospital, NO-5021 Bergen, Norway
,
Ove Furnes Section for Medical Statistics, Armauer Hansens Hus, University of Bergen, Haukeland Hospital, NO-5021 Bergen, Norway, E-mail: [email protected], Department of Orthopaedics, Haukeland University Hospital, NO-5021 Bergen, Norway
&
Stein Emil Vollset Section for Medical Statistics, Armauer Hansens Hus, University of Bergen, Haukeland Hospital, NO-5021 Bergen, Norway, E-mail: [email protected], Department of Orthopaedics, Haukeland University Hospital, NO-5021 Bergen, Norway
Pages 392-399 | Published online: 08 Jul 2009

  • Bergqvist D, Benoni G, Bjorgell O, Fredin H, Hedlundh U, Nicolas S, Nihson P, Nylander G. Low-molecular-weight heparin (enoxaparin) as prophylaxis against venous thromboembolism after total hip replacement. N Engl J Med 1996: 335: 696-700.
  • Borris L C, Lassen M R, Jensen H P, Andersen B S, Poulsen K A.Perioperative thrombosis prophylaxis with low molecular weight heparins in elective hip surgery. Clinical and economic considerations. Int J Clin Pharmacol Ther 1994: 32: 262-8.
  • Bulstrode C J.Commentary on thromboprophylaxis in hip replacement surgery (Dahl O E.Acta Orthop Scand 1998: 69: 339-42). Acta Orthop Scand 1998: 69: 343-4.
  • Collins R. Scrimgeour A, Yusuf S, Peto R. Reduction in fatal pulmonary embolism and venous thrombosis by perioperative administration of subcutaneous heparin-overview of results of randomized trials in general, orthopedic. and urologic surgery. N Engl J Med 1988; 318: 1162-73.
  • Colwell C W.Jr., Collis D K, Paulson R, McCutchen J W, Bigler G T, Lutz S, Hardwick M E.Comparison of enoxaparin and warfarin for the prevention of venous thromboembolic disease after total hip arthroplasty. Evaluation during hospitalisation and three months after discharge. J Bone Joint Surg (Am) 1999: 81: 932-40.
  • Comp PC. Voegeli T. McCutchen J W.Skoutakis V A.Trowbridge A. Overdyke W L.A comparison of danaparoid and warfarin for prophylaxis against deep vein thrombosis after total hip replacement: The Danaparoid Hip Arthroplasty Investigators Group. Orthopedics 1998: 21: 1123-8.
  • Dahl O E.Andreassen G. Aspelin T. Muller C. Mathiesen P, Nyhus S. Abdelnoor M. Solhaug J H, Arnesen H. Prolonged thromboprophylaxis following hip replacement surgery-results of a double-blind, prospective, randomised, placebo-controlled study with dalteparin (Fragmin). Thromb Haemost 1997; 77: 26-31.
  • Dearborn J T.Harris W H.Postoperative mortality after total hip anhroplasty. An analysis of deaths after two thousand seven hundred and thirty-six procedures. J Bone Joint Surg (Am) 1998; 80: 1291-4.
  • Dunsmuir R A.Allan D B.Davidson L A.Early postoperative mortality following primary total hip replacement. J R Coll Surg Edinb 1996: 41: 185-7.
  • Eriksson B I, Kalebo P, Anthymyr B A, Wadenvik H, Tengbora L, Risberg B. Prevention of deep-vein thrombosis and pulmonary embolism after total hip replacement. Comparison of low-molecular-weight heparin and unfractionated heparin. J Bone Joint Surg (Am) 1991; 73: 484-93.
  • Fender D, Harper W M.Thompson J R.Gregg P J.Mortality and fatal pulmonary embolism after primary total hip replacement. Results from a regional hip register. J Bone Joint Surg (Br) 1997; 79: 896-9.
  • Freedman K B.Brookenthal K R.Fitzgerald R H.Jr., Williams S, Lonner J H.A meta-analysis of thromboembolic prophylaxis following elective total hip arthroplasty. J Bone Joint Surg (Am) 2000; 82: 929-38.
  • Havelin L I.Engesaeter L B.Espehaug B. Furnes O, Lie S A.Vollset S E.The Norwegian Arthroplasty Register 11 years and 73.000 arthroplasties. Acta Orthop Stand 2000; 71: 337-53.
  • Imperiale T F.Speroff T. A meta-analysis of methods to prevent venous thromboembolism following total hip replacement. JAMA 1994: 271: 1780-5.
  • Kakkar V V.et al. Prevention of fatal postoperative pulmonary embolism by low doses of heparin. An international multicentre trial. Lancet 1975; 2: 45-51
  • Karwinski B. Cerebrovascular disease at autopsy and in the death statistics for the county of Hordaland, Norway. APMIS 1993: 101: 269-74.
  • Lie S A, Engesaeler I. B, Havelin L I, Gjessing H K, Vollset S E.Mortality after total hip replacement: 0-10-year follow-up of 39.543 patients in the Norwegian Arthroplasty Register. Acta Orthop Scand 2000; 71: 19-27.
  • Mohr D N.Silverstein M D.Murtaugh P A.Harrison J M.Prophylactic agents for venous thrombosis in elective hip surgery. Meta-analysis of studies using venographic assessment. Arch Intern Med 1993; 153: 2221-8.
  • Murray D W, Britton A R.Bulstrode C J.Thromboprophylaxis and death after total hip replacement J Bone Joint Surg (Br) 1996: 78: 863-70.
  • O'Brian J. et al. Prevention of pulmonary embolism and deep vein thrombosis with low dose aspirin: Pulmonary Embolism Prevention (PEP) trial. Lancet 2000; 355: 1295-302.
  • Osswald B R.Blackstone E H.Tochtermann U, Thomas G. Vahl C F.Hagl S. The meaning of early mortality after CABG. Eur J Cardiothorac Surg 1999: 15: 401-7.
  • Planes A. Vochelle N. Darmon J Y.Fagola M. Bellaud M. Huel Y. Risk of deep-venous thrombosis after hospital discharge in patients having undergone total hip replacement: double-blind randomised comparison of enoxaparin versus placebo. Lancet 1996; 348: 224-8.
  • Prentice C R.Thromboprophylaxis-which treatment for which patient? J Bone Joint Surg (Br) 2000; 82: 483-5
  • Salvati E A.Pellegrini V D.Jr. Sharrock N H, Lotke P A.Murray D W.Potter H, Westrich G H.Recent advances in venous thromboembolic prophylaxis during and after total hip replacement. J Bone Joint Surg (Am) 2000; 82: 252-70.
  • Seagroatt V. Goldacre M. Measures of early postoperative mortality: beyond hospital fatality rates. BMJ 1994; 309: 361-5.
  • Seagroatt V. Tan H S.Goldacre M, Bulstrode C, Nugent I. Gill L. Elective total hip replacement: incidence, emergency readmission rate, and postoperative mortality. BMJ 1991: 303: 1431-5.
  • Thomas D P.Whither thromboprophylaxis after total hip replacement? J Bone Joint Surg (Br) 2000; 82: 469-72.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.